Open Access · CC BY 3.0
mRNA therapeutics beyond vaccines: dosing precision challenges and clinical translation framework
RSC Pharmaceutics · 2026 · 3 (1) · 10-21
DOI: 10.1039/d5pm00159e ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Pharmaceutics, 2026. Verfasst von Sarfaraz K. Niazi. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Messenger RNA (mRNA) therapeutics have emerged as a transformative platform following the success of COVID-19 vaccines.
Zitieren
APA
Niazi, S. K. (2026). mRNA therapeutics beyond vaccines: dosing precision challenges and clinical translation framework. RSC Pharmaceutics, 3(1), 10-21. https://doi.org/10.1039/d5pm00159e
Vancouver
Niazi SK. mRNA therapeutics beyond vaccines: dosing precision challenges and clinical translation framework. RSC Pharmaceutics. 2026;3(1):10-21. doi:10.1039/d5pm00159e
BibTeX
@article{Niazi2026,
author = {Niazi, Sarfaraz K.},
title = {mRNA therapeutics beyond vaccines: dosing precision challenges and clinical translation framework},
journal = {RSC Pharmaceutics},
year = {2026},
volume = {3},
number = {1},
pages = {10--21},
doi = {10.1039/d5pm00159e}
}
EUVIMED